Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FAHD2A mRNA | CTD | PMID:36331819 | 1,1-dichloroethene | decreases expression | EXP | | 6480464 | vinylidene chloride results in decreased expression of FAHD2A mRNA | CTD | PMID:26682919 | 1,2-dimethylhydrazine | decreases expression | EXP | | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of FAHD2A mRNA | CTD | PMID:22206623 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FAHD2A mRNA | CTD | PMID:19465110 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of FAHD2A mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FAHD2A mRNA | CTD | PMID:19770486 | acrylamide | decreases expression | ISO | FAHD2A (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of FAHD2A mRNA | CTD | PMID:32763439 | aflatoxin B1 | affects expression | ISO | FAHD2A (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of FAHD2A protein | CTD | PMID:20106945 | aflatoxin B1 | decreases expression | ISO | FAHD2A (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of FAHD2A mRNA | CTD | PMID:27153756 | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of FAHD2A mRNA | CTD | PMID:19770486 | all-trans-retinoic acid | decreases expression | ISO | FAHD2A (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of FAHD2A mRNA | CTD | PMID:33167477 | Aroclor 1254 | increases expression | EXP | | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of FAHD2A mRNA | CTD | PMID:23650126 | arsenous acid | increases expression | ISO | FAHD2A (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of FAHD2A mRNA | CTD | PMID:25258189 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of FAHD2A mRNA | CTD | PMID:22228805 | benzo[a]pyrene | decreases methylation | ISO | FAHD2A (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of FAHD2A 5' UTR | CTD | PMID:27901495 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of FAHD2A mRNA | CTD | PMID:26063408 and PMID:33221593 | bisphenol A | decreases expression | ISO | FAHD2A (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of FAHD2A protein | CTD | PMID:33376534 | carbon nanotube | decreases expression | EXP | | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | cobalt dichloride | decreases expression | ISO | FAHD2A (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of FAHD2A mRNA | CTD | PMID:19376846 | cocaine | affects expression | ISO | FAHD2A (Homo sapiens) | 6480464 | Cocaine affects the expression of FAHD2A protein | CTD | PMID:19393250 | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of FAHD2A mRNA | CTD | PMID:19770486 | cyclosporin A | decreases expression | ISO | FAHD2A (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of FAHD2A mRNA | CTD | PMID:20106945 and PMID:25562108 | diarsenic trioxide | increases expression | ISO | FAHD2A (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of FAHD2A mRNA | CTD | PMID:25258189 | epoxiconazole | increases expression | EXP | | 6480464 | epoxiconazole results in increased expression of FAHD2A mRNA | CTD | PMID:35436446 | hydroquinone | decreases expression | ISO | FAHD2A (Homo sapiens) | 6480464 | hydroquinone results in decreased expression of FAHD2A mRNA | CTD | PMID:31256213 | inulin | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of FAHD2A mRNA | CTD | PMID:36331819 | ivermectin | decreases expression | ISO | FAHD2A (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of FAHD2A protein | CTD | PMID:32959892 | leflunomide | decreases expression | ISO | FAHD2A (Homo sapiens) | 6480464 | leflunomide results in decreased expression of FAHD2A mRNA | CTD | PMID:28988120 | nickel atom | decreases expression | ISO | FAHD2A (Homo sapiens) | 6480464 | Nickel results in decreased expression of FAHD2A mRNA | CTD | PMID:25583101 | nickel sulfate | increases expression | ISO | FAHD2A (Homo sapiens) | 6480464 | nickel sulfate results in increased expression of FAHD2A mRNA | CTD | PMID:22714537 | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of FAHD2A mRNA | CTD | PMID:17562736 | perfluorohexanesulfonic acid | decreases expression | EXP | | 6480464 | perfluorohexanesulfonic acid results in decreased expression of FAHD2A mRNA | CTD | PMID:37995155 | perfluorooctane-1-sulfonic acid | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FAHD2A mRNA more ... | CTD | PMID:36331819 | perfluorooctanoic acid | increases expression | ISO | FAHD2A (Homo sapiens) | 6480464 | perfluorooctanoic acid results in increased expression of FAHD2A protein | CTD | PMID:26879310 | pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of FAHD2A mRNA | CTD | PMID:19710929 | pirinixic acid | multiple interactions | ISO | FAHD2A (Homo sapiens) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of FAHD2A mRNA | CTD | PMID:19710929 | quercitrin | decreases expression | ISO | FAHD2A (Homo sapiens) | 6480464 | quercitrin results in decreased expression of FAHD2A mRNA | CTD | PMID:25193878 | senecionine | increases expression | EXP | | 6480464 | senecionine results in increased expression of FAHD2A protein | CTD | PMID:35357534 | sodium arsenite | increases expression | ISO | FAHD2A (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of FAHD2A mRNA | CTD | PMID:22714537 | succimer | multiple interactions | EXP | | 6480464 | [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FAHD2A mRNA | CTD | PMID:26378955 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of FAHD2A mRNA | CTD | PMID:31919559 | trichostatin A | increases expression | ISO | FAHD2A (Homo sapiens) | 6480464 | trichostatin A results in increased expression of FAHD2A mRNA | CTD | PMID:28542535 | trovafloxacin | decreases expression | EXP | | 6480464 | trovafloxacin results in decreased expression of FAHD2A mRNA | CTD | PMID:35537566 | valproic acid | decreases expression | ISO | FAHD2A (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of FAHD2A mRNA | CTD | PMID:23179753 and PMID:29154799 | valproic acid | affects expression | ISO | FAHD2A (Homo sapiens) | 6480464 | Valproic Acid affects the expression of FAHD2A mRNA | CTD | PMID:25979313 | |